You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

4SC

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clinical Phenotypic Characteristics of SC26A4

Recruiting
  • Hearing Loss
  • Pendred Syndrome
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Jul 24, 2023

    Malignant Melanoma Trial in Germany, Italy (4SC-202 in combination with Pembrolizumab)

    Completed
    • Malignant Melanoma
    • 4SC-202 in combination with Pembrolizumab
    • Essen, Germany
    • +6 more
    Feb 3, 2022

    Multicenter Observational Study of PSC and IgG4-SC in China

    Recruiting
    • Primary Sclerosing Cholangitis
    • IgG4-related Sclerosing Cholangitis
    • Only observation
    • Shanghai, 上海市, China
      RenJi Hospital
    Jul 18, 2022

    Urothelial Carcinoma Trial in Amsterdam, Nijmegen (Nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • Amsterdam, Netherlands
    • +1 more
    Jul 28, 2022

    Crohn's Disease Trial in Chicago (Vedolizumab, Adalimumab, Ustekinumab)

    Not yet recruiting
    • Crohn's Disease
    • Chicago, Illinois
      University of Chicago Medicine
    Sep 13, 2023

    Posttransplant Lymphoproliferative Disorder Trial in Germany (Rituximab sc, Rituximab sc consolidation, Rituximab sc combined

    Completed
    • Posttransplant Lymphoproliferative Disorder
    • Rituximab sc
    • +3 more
    • Aachen, Germany
    • +17 more
    Aug 22, 2022

    Hypercholesterolemia Trial in Beijing (IBI306 450mg SC Q4W, Placebo SC Q4W, IBI306 600mg SC Q6W)

    Completed
    • Hypercholesterolemia
    • IBI306 450mg SC Q4W
    • +3 more
    • Beijing, China
      Peking University First Hospital
    Apr 2, 2022

    HIV Trial in Worldwide (PGDM1400LS (5mg/kg, IV), PGDM1400LS (20mg/kg, IV), PGDM1400LS (20mg/kg, SC))

    Recruiting
    • HIV Infections
    • PGDM1400LS (5mg/kg, IV)
    • +16 more
    • San Francisco, California
    • +13 more
    Aug 12, 2022

    Heart Failure Trial in United States (PB1046 Injection, Placebo Injection)

    Completed
    Has Results
    • Heart Failure
    • PB1046 Injection
    • Placebo Injection
    • Anniston, Alabama
    • +4 more
    Jun 20, 2022

    Diffuse Large B-cell Lymphoma (DLBCL) Trial in Worldwide (CTL019)

    Completed
    • Diffuse Large B-cell Lymphoma (DLBCL)
    • Tisagenlecleucel
    • Lymphodepleting chemotherapy
    • San Francisco, California
    • +25 more
    Jan 27, 2023

    Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)

    Recruiting
    • Atypical Endometrial Hyperplasia
    • Endometrial Carcinoma
    • Megestrol Acetate
    • Pterostilbene
    • Duarte, California
      City of Hope Medical Center
    Oct 12, 2022

    Asthma, Allergic Trial in Hamilton, Saskatoon (Tezepelumab, Placebo)

    Not yet recruiting
    • Asthma, Allergic
    • Hamilton, Ontario, Canada
    • +1 more
    Feb 22, 2023

    HIV-1-infection, Subtype b Trial (Decitabine cycle 1, Romidepsin cycle 1, Decitabine cycle 2)

    Recruiting
    • HIV-1-infection, Subtype b
    • Decitabine cycle 1
    • +7 more
    • Bruxelles, Belgium
    • +2 more
    Jan 30, 2023

    Asthma Trial in India (Prednisone/ Prednisolone, Mepolizumab, Salbutamol)

    Recruiting
    • Asthma
    • Prednisone/ Prednisolone
    • +2 more
    • Bangalore, Karnataka, India
    • +10 more
    Feb 7, 2022

    HIV-1-infection Trial (UB-421 SC)

    Not yet recruiting
    • HIV-1-infection
    • UB-421 SC
    • (no location specified)
    May 12, 2022

    Respiratory System Trial in Nice (Bronchoscopy)

    Unknown status
    • Respiratory System
    • Bronchoscopy
    • Nice, France
      CHU de Nice
    Aug 26, 2020

    NSCLC Trial in Worldwide (PDR001, Cisplatin, Gemcitabine)

    Terminated
    • Non-small Cell Lung Cancer
    • Fayetteville, Arkansas
    • +22 more
    Aug 11, 2022

    Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program Trial in Worldwide

    Recruiting
    • Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program
    • Previously treated CAR-T patients
    • Phoenix, Arizona
    • +71 more
    Nov 14, 2022

    Burns Trial in Toronto (Integra®, Integra®-SC)

    Not yet recruiting
    • Burns
    • Integra®
    • Integra®-SC
    • Toronto, Ontario, Canada
      Sunnybrook Health Sciences Centre
    Apr 21, 2022

    Advanced Solid Tumor Trial in Worldwide (CLR457)

    Terminated
    • Advanced Solid Tumor
    • Boston, Massachusetts
    • +6 more
    Dec 2, 2021

    Psoriasis Trial in Canada, United States (LY3462817 - IV, LY3462817 - SC, Placebo - IV)

    Terminated
    • Psoriasis
    • LY3462817 - IV
    • +5 more
    • Los Angeles, California
    • +12 more
    Feb 28, 2022

    Total Knee Arthroplasty (Postoperative Pain), Total Hip Arthroplasty(Postoperative Pain) Trial in Charleston (4 Real sessions of

    Completed
    Has Results
    • Total Knee Arthroplasty (Postoperative Pain)
    • Total Hip Arthroplasty(Postoperative Pain)
    • 4 Real sessions of Transcranial Direct Current Stimulation
    • +3 more
    • Charleston, South Carolina
      Ralph H. Johnson VA Medical Center, Charleston, SC
    Jun 24, 2022

    Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, Recurrent CNS Tumor, Adult Trial in Seattle (SC-CAR4BRAIN)

    Not yet recruiting
    • Diffuse Intrinsic Pontine Glioma
    • +4 more
    • SC-CAR4BRAIN
    • Seattle, Washington
      Seattle Children's Hospital
    Mar 3, 2023

    Generalized Lipodystrophy Trial in United States (Metreleptin)

    Recruiting
    • Generalized Lipodystrophy
    • Birmingham, Alabama
    • +7 more
    Oct 28, 2022

    Follicular Lymphoma Trial in Worldwide (Mosunetuzumab (IV), Tocilizumab, Lenalidomide)

    Recruiting
    • Follicular Lymphoma
    • Mosunetuzumab (IV)
    • +3 more
    • Duarte, California
    • +21 more
    Jan 10, 2023